News & Analysis on Clinical Trial Services & Contract Research And Development
A chewing gum to treat Type 2 diabetes and obesity is one step closer to reality after developers of the technology, Generex, formed a new partnership with Danish medicinal chewing gum specialists, Fertin Pharma, to develop the product.
Biotech company Genzyme Pharmaceuticals and drug delivery firm Brookwood Pharmaceuticals are now working together to create new ways of delivering peptide-based drugs.
Odyessa Thera has announced it has been granted a US patent for its single-and multi-colour protein-fragment complementation assays (PCA), which can be applied to high throughput drug discovery.
Testing services and contract manufacturing firm Microtest has announced it will invest $7.5m (€6m) in new facilities to expand its offering of pharmaceutical and virology testing services and fill/finish production capacity.
Biopharmaceutical firm Protherics has acquired a new adjuvant from Dutch company CoVaccine that it will use for its hypertension vaccine, hoping to boost antibody production by tenfold.
The US Food and Drug Administration (FDA) has urged the pharma industry to develop preservative-free nasal sprays, however, there is currently a vacuum of manufacturers that can fulfil such a requirement.
A recently published report has highlighted the use of antibiotics in the rearing of fish could promote bacterial resistance leading to the evolution of resistant strains of bacteria in humans as well as the fish themselves.